News

Latest news

Hide mandatory notifications of trade

Bionor Pharma Presenting Q1 2013 Interim Report by Webcast Wednesday 15 May at 8.30 am CEST

07.05.2013 - Bionor Pharma ASA (OSE:BIONOR) will announce its Q1 2013 interim report Wednesday 15 May 2013 at 8.30.

We are pleased to invite you to join in on our international webcast (and teleconference) for analysts, investors and other stakeholders at 08.30 CEST to discuss the progress and results with Bionor Pharma’s senior management.

Webcast
A live audio webcast of the call will be available together with the slide presentation at
http://www.media-server.com/m/p/i6exvxen

Call numbers
It is also possible to call in (if a computer is not available, and for ability to ask questions). The numbers are: +44(0)20 3427 1900 (UK), +1646 254 3388 (US), +472316 2771 (Norway), +4532 71 16 59 (Denmark) or +46(0)8 5065 3936 (Sweden) and request to be connected to the Bionor Pharma’s teleconference (confirmation code 5253735). Please use a quiet room.


Schedule for the webcast /teleconference 15 May (CEST time)

08.25 -Log in to the webcast-link, and/or call

08.30 -Review of results by Bionor Pharma’s senior management.
 -Questions and answers.

One week replay
There will be a replay facility available for one week one hour following the teleconference. The number to dial is +44(0)20 3427 0598 (UK), +1347 366 9565 (US), +472100 0498 (Norway), +4532 71 09 13 (Denmark) or +46(0)8 5051 3897 (Sweden), access code for all numbers is 5253735#.


Information about Bionor Pharma is available at www.bionorpharma.com


Bionor Pharma ASA

Hilde Aalling Syvertsen,
-Director Communications & Corporate Affairs 

Tel +47 23 01 09 60